Onlikon: Announcement on the actual controller of the company\'s stock pledged repurchase partial repurchase, release the pledge, and then carry out a stock pledge repurchase transaction
Onlikon: Announcement on the actual controller of the company\'s stock pledged repurchase partial repurchase, release the pledge, and then carry out a stock pledge repurchase transaction
Onlikon: Announcement on the subsidiary\'s renewal of the “Veterinary Drug GMP Certificate” and passing the GMP compliance inspection
Onlikon: Announcement on the extension and supplementary pledge of part of the company\'s actual controller\'s equity pledge
Onlykang: Announcement on shareholding information for the top ten shareholders and the top ten shareholders with unlimited sale conditions on share repurchases
Onlycan: Repurchase Report
Onlikon: Announcement on Resolutions of the Sixth Meeting of the Fourth Board of Directors
Onlikon: Announcement on the plan to repurchase the company\'s shares and receipt of the “Loan Pledge”
Onlikon: 002940 Onlikon Investor Relations Management Information 20241031
Onlikon: Third Quarter 2024 Report
Onlikon: Announcement on the expiration of the company\'s senior management holdings reduction plan
Onlikon: Announcement on the actual controller\'s renewal of the concerted action agreement
Onlikon: Announcement on Subsidiaries Obtaining Drug Registration Certificates
Onlikon: Announcement on the extension of the term of the first employee stock ownership plan
Onlikon: Announcement on Resolutions of the Fourth Meeting of the Fourth Board of Directors
Onlikon: 002940 Onlikon Investor Relations Management Information 20240913
Onlikang: Announcement on the completion of the registration of industrial and commercial changes by the subsidiary Jiangxi Chundi Biotechnology Co., Ltd.
Onlikon: Announcement on Continued Supervision of Changes in Sponsor Entities
Onlikon: 002940 Onlikon Investor Relations Management Information 20240908
Onlikon: Announcement on the expiration of the repurchase period of the company\'s shares and the completion of the implementation of the repurchase
No Data
No Data